Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-636-2598
Fax+1 216-444-9464
Dr. Kruse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2014 - 2017
UPMC Medical EducationResidency, Internal Medicine, 2011 - 2014
Case Western Reserve University School of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2014 - 2026
PA State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Start of enrollment: 2025 Apr 01
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- 2 citationsReimagining Deintensification for Low-Risk Breast Cancer.Chirag Shah, Megan Kruse, Zahraa Al-Hilli
JCO Oncology Practice. 2025-03-01 - 1 citationsA 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conser...Frank Vicini, Chirag Shah, Karuna Mittal, Jame Abraham, Megan Kruse
Clinical Breast Cancer. 2025-02-01 - 2 citationsProgress in immune checkpoint inhibition in early-stage triple-negative breast cancer.Ahmed Mohamed, Megan Kruse, Jennifer Tran
Expert Review of Anticancer Therapy. 2023-10-26
Press Mentions
Cleveland Clinic: First Patient To Receive Breast Cancer Vaccine Shares Health JourneyApril 17th, 2023- First Breast Cancer Vaccine Trial Participant Shares Experience PKGApril 13th, 2023
- Invasive Lobular Carcinoma a Distinctive, Understudied Breast Cancer SubtypeJanuary 5th, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
